On Invalid Date, Sagimet Biosciences (NASDAQ: SGMT) reported Q4 2023 earnings per share (EPS) of -$2.66, up 93.19% year over year. Total Sagimet Biosciences earnings for the quarter were -$8.15 million. In the same quarter last year, Sagimet Biosciences's earnings per share (EPS) was -$39.07.
As of Q2 2024, Sagimet Biosciences's earnings has grown year over year. Sagimet Biosciences's earnings in the past year totalled -$27.88 million.
What was SGMT's revenue last quarter?
On Invalid Date, Sagimet Biosciences (NASDAQ: SGMT) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Sagimet Biosciences's revenue was $0.00.
What was SGMT's revenue growth in the past year?
As of Q2 2024, Sagimet Biosciences's revenue has grown null year over year. Sagimet Biosciences's revenue in the past year totalled $2.00 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.